Activity Stream
@moatrx
• 3 weeks ago
Posted a new blog:
US SICKLE CELL DISEASE Competitive Intelligence
US SICKLE CELL DISEASE Competitive Intelligence
Casgevy and Lyfgenia reset a 100,000-patient US market, yet hydroxyurea, proven decades ago, still reaches only 25-30% of eligible patients.
Sickle cell disease...
